Navigation Links
UCI receives $5M from Edwards Lifesciences
Date:9/12/2007

Irvine, Calif., September 12, 2007 - UC Irvines Henry Samueli School of Engineering has received a $5 million gift from Edwards Lifesciences Corporation to establish a center focused on researching and developing the next generation of cardiovascular devices.

The Edwards Lifesciences Center for Advanced Cardiovascular Technology will promote interaction and collaboration among students, faculty members and experts by incorporating both undergraduate and graduate programs related to heart and vascular diseases. The programs will be directed by UCIs Department of Biomedical Engineering, and will involve a variety of other disciplines, including students from the Integrated Nanosystems Research Facility, the California Institute for Telecommunications and Information Technology, the Donald Bren School of Information and Computer Sciences, the Beckman Laser Institute, and UCIs Schools of Medicine, Physical Sciences, and Biological Sciences.

The center also will provide a training environment for hosting prominent experts in the field of cardiovascular technology. It will be located in Engineering 3, a new building on the UCI campus scheduled for completion in August 2009.

A national search is under way for a director, who will be charged with establishing a strategic plan and forming a leadership council to determine the centers specific direction.

Our goal is to create an interdisciplinary facility that encourages students, faculty, researchers and visiting scholars to collaborate and exchange new ideas to drive the development of cardiovascular advancements and devices, said Steven C. George, M.D., William J. Link chair and professor of the Department of Biomedical Engineering, who is spearheading the centers development. The Edwards Lifesciences Center will thoroughly examine the integration of numerous disciplines, such as materials science, computer science, advanced imaging and microfabrication, or the manufacturing of devices with precision at levels much smaller than a millimeter, which all have the potential to lead to implantable devices that can help treat cardiovascular disease.

The Department of Biomedical Engineering, which was established in 2002 and is comprised of 16 faculty members, focuses on education, training, research and technology in areas like manufacturing miniature devices, biomedical lasers, developing computer simulations, and designing artificial tissues in the area of tissue engineering to further advance biomedical technology.

We are pleased to closely collaborate with Edwards Lifesciences, an international leader in cardiovascular technology, to develop a center that combines exceptional faculty, resources and tools to advance this evolving field, said Nicolaos G. Alexopoulos, dean of The Henry Samueli School of Engineering. UC Irvine is located in one of the largest medical device company clusters in the world, which I believe uniquely positions us to address this critical health care area and initiate a world class center.

Irvine-based Edwards Lifesciences, which develops products and technologies to treat advanced cardiovascular disease, is granting the multiyear gift through the Edwards Lifesciences Fund. The fund was established to support advancements in knowledge and improvements in quality of life to help those affected by cardiovascular disease, particularly in the communities where the companys employees live and work.

We are proud to partner with a neighbor that is as accomplished and committed to excellence as UC Irvine to establish a center devoted to transformational cardiovascular technology research, said Michael A. Mussallem, Edwards Lifesciences' chairman and CEO. This grant is a testament to our dedication to providing innovative solutions for people fighting cardiovascular disease, as well as our commitment to strengthening the communities in which we live and work.


'/>"/>

Contact: Jason Mednick
jmednick@uci.edu
949-824-5951
University of California - Irvine
Source:Eurekalert

Related biology news :

1. DuPonts first biologically derived polymer receives global recognition
2. OneWorld Health drug receives Orphan designation from U.S. and European regulatory agencies
3. Research on antibiotics receives historical recognition
4. Anthrax test, developed by army and CDC, receives FDA approval
5. Research team receives $7.5 million to study cassava
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2017)... UBM,s Advanced Design and Manufacturing event in ... and evolving technology through its 3D Printing and Smart ... the expo portion of the event and feature a ... on trending topics within 3D printing and smart manufacturing. ... will take place June 13-15, 2017 at the Jacob K. ...
(Date:4/11/2017)... 11, 2017 NXT-ID, Inc. (NASDAQ:   ... announces the appointment of independent Directors Mr. Robin D. ... Board of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , ... forward to their guidance and benefiting from their considerable expertise ...
(Date:4/4/2017)... NEW YORK , April 4, 2017   ... solutions, today announced that the United States Patent and ... The patent broadly covers the linking of an iris ... the same transaction) and represents the company,s 45 th ... our latest patent is very timely given the multi-modal ...
Breaking Biology News(10 mins):
(Date:8/15/2017)... ... August 15, 2017 , ... Nanomedical Diagnostics ... biotherapeutics development, announces the launch of the new NHS Agile biosensor chip ... binding data for a wide range of molecules, including small and large molecules, ...
(Date:8/15/2017)... ... August 15, 2017 , ... ... of 6” modular downlights designed to stay tightly sealed and perform efficiently for ... damp and wet location listings just aren't enough, such as: hospitals; behavioral health ...
(Date:8/15/2017)... ... 2017 , ... JULABO USA introduces its new website ... it easy to navigate through the site whether you’re in the office, in ... educational industry content and visit the company’s social media accounts, all on one ...
(Date:8/14/2017)... ... 2017 , ... The Conference Forum has confirmed the one-day agenda ... September 6, 2017 at the Marriott Copley Place in Boston, MA. , Returning as ... Regulatory Strategy, Pfizer Innovative Research Lab, Pfizer, who leads 19 industry speakers in discussing ...
Breaking Biology Technology: